Advertisement Tryton gets CE mark approval for Side-Branch Stent - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Tryton gets CE mark approval for Side-Branch Stent

Tryton Medical has received CE mark approval for its Side Branch Stent for the treatment of the entire spectrum of coronary artery bifurcation disease.

The Tryton Side-Branch Stent is a high performance cobalt chromium balloon-expandable coronary stent.

Richard Davis, chief technology officer of Tryton, said: “CE Mark will allow us to bring this important technology to market in Europe. A market launch is planned for May in conjunction with EuroPCR 2008.”